Recently, the details of DOG-1 have been revealed gradually by reported expression in poorly differentiated tumors [21, 22], such as sarcomatous carcinoma of the liver, in lymph node metastasis of colorectal cancer [23], and as a poor prognostic factor in breast cancer [24]. This evidence concerns the gene ANO1 and breast carcinoma.